---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-154095"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2022-05-18T23:59:59+00:00"
generated_at: "2026-06-25T09:46:51.034315+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad updates share repurchase activity: $125M repurchased QTD

## Summary
- Quarter-to-date through May 17, 2022, Bio-Rad repurchased $125M of Class A common stock.
- Repurchased 255k shares at an average price of $489.65 per share.
- Total repurchased under program: $351.9M; remaining authorization: $98.1M.
- Buyback program authorized Nov 2017 for $250M, increased by $200M in July 2020.

## SEC filing metadata
- accession: 0001193125-22-154095
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2022-05-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000119312522154095/0001193125-22-154095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000119312522154095/d355304d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-154095
- JSON: https://secwatch.observer/filing/0001193125-22-154095.json
- Plain text: https://secwatch.observer/filing/0001193125-22-154095.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.